Monoclonal Antibodies for Early Treatment of COVID-19 in a World of Evolving SARS-CoV-2 Mutations and Variants.

Pogue, Jason M; Lauring, Adam S; Gandhi, Tejal N; Marshall, Vincent D; Eschenauer, Gregory A; Nagel, Jerod L; Baang, Ji Hoon; Zhou, Shiwei; Valesano, Andrew L; Petty, Lindsay A

Pogue, Jason M; Lauring, Adam S; Gandhi, Tejal N; Marshall, Vincent D; Eschenauer, Gregory A; Nagel, Jerod L; Baang, Ji Hoon; Zhou, Shiwei; Valesano, Andrew L; Petty, Lindsay A.

Afiliação

Pogue JM; University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
Lauring AS; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Gandhi TN; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Marshall VD; University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
Eschenauer GA; Department of Pharmacy, Michigan Medicine, Ann Arbor, Michigan, USA.
Nagel JL; University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
Baang JH; Department of Pharmacy, Michigan Medicine, Ann Arbor, Michigan, USA.
Zhou S; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Valesano AL; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Petty LA; University of Michigan School of Medicine, Ann Arbor, Michigan, USA.

Open Forum Infect Dis ; 8(7): ofab268, 2021 Jul.

Article em En | MEDLINE | ID: mdl-34291118

Palavras-chave

COVID-19; SARS-CoV-2; bamlanivimab; bamlanivimab and etesevimab; casirivimab and imdevimab; variants

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google